StockClub

RARE

RAREUltragenyx Pharmaceutical Inc.$ --
Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.

RARE

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
207M USD
YoY +25.5%
Operating Income
-114M USD
YoY +6.8%
Net Income
-129M USD
YoY +3.3%
EPS
-1.29$
YoY +7.2%

Revenue

$672.7M
FY2024 Q1$108.8M
$108.8M
Q1
FY2024 Q2$255.9M
$255.9M
Q2
FY2024 Q3$395.4M
$395.4M
Q3
FY2024 Q4$560.2M
$560.2M
Q4
FY2025 Q1$139.3M
$139.3M
Q1
FY2025 Q2$305.8M
$305.8M
Q2
FY2025 Q3$465.7M
$465.7M
Q3
FY2025 Q4$672.7M
$672.7M
Q4
Actual
+$112.5M (+20.1%)

Net Income

$-575.4M
FY2024 Q1$-170.7M
$-170.7M
Q1
FY2024 Q2$-302.3M
$-302.3M
Q2
FY2024 Q3$-435.8M
$-435.8M
Q3
FY2024 Q4$-569.2M
$-569.2M
Q4
FY2025 Q1$-151.1M
$-151.1M
Q1
FY2025 Q2$-266M
$-266M
Q2
FY2025 Q3$-446.4M
$-446.4M
Q3
FY2025 Q4$-575.4M
$-575.4M
Q4
Actual
$-6.3M (-1.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$271M
Est:$250M
FY2020BEAT
$271M
FY2021MISS
Actual:$351.4M
Est:$351.8M
FY2021MISS
$351.4M
FY2022BEAT
Actual:$363.3M
Est:$361.7M
FY2022BEAT
$363.3M
FY2023MISS
Actual:$434.2M
Est:$481.3M
FY2023MISS
$434.2M
FY2024BEAT
Actual:$560.2M
Est:$547.6M
FY2024BEAT
$560.2M
FY2025BEAT
Actual:$673M
Est:$664.7M
FY2025BEAT
$673M

Analyst Estimates